Impact Factor
2.76
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.49
369 total citations
h5-index
19
h5 depth signal
Cited share
46.5%
120 of 258
Total citations
369
Citation footprint
Metric signal
1.45
External metric anchor
Self-citation
0.0%
0 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
350
China
162
Japan
70
Singapore
46
Italy
45
Citing Fields of Research
Oncology
268
Digestive Disorders
135
Liver & Colon Cancer
122
Brain Imaging
114
Breast Cancer
114
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
913
Articles tracked across the journal lifetime
Indexed publication set
258
120 cited publications
Last 12 months
95
15.8 publications/month
Open access share
71.6%
68 OA publications in the last year
Leading citing country
United States
350 citing publications
Leading citing field
Oncology
268 citing publications
Latest tracked publication
1 August 2026
10 recent records available
Coverage & Indexing History
v4n1, Mar. 2015-
v4n1, Mar. 2015- ; selected citations only before this date
Research Focus & Classification
Indexed Subjects
Lung Cancer
Oncology
Liver & Colon Cancer
Breast Cancer
Digestive Disorders
Immunology
Issuing & Sponsoring Bodies
Contributor
Society for Translational Cancer Research
Broad Categories
Neoplasms
Brain Imaging
Digestive Disorders
Lung Cancer
Liver & Colon Cancer
Endocrinology & Metabolism
Prostate Cancer
MeSH Descriptors
China
Medical Oncology
Neoplasms
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.21037/cco-2026-0061
Open DOI
Separate the wheat from the chaff: the limited and context-dependent role of immune checkpoint inhibitors in platinum-resistant ovarian cancer
Separate the wheat from the chaff: the limited and context-dependent role of immune checkpoint inhibitors in platinum-resistant ovarian cancer
02
DOI 10.21037/cco-2026-1-0032
Open DOI
An interview-based study of Asian American non-smoker lung cancer in the United States
An interview-based study of Asian American non-smoker lung cancer in the United States
03
DOI 10.21037/cco-2026-1-0029
Open DOI
A nomogram integrating clinical and multimodal ultrasound features for pretreatment prediction of HER2 status in breast cancer: a retrospective study
Background: The effective management of heterogeneous breast cancer relies on accurate human epidermal growth factor receptor 2 (HER2) status assessment to guide targeted therapy. Currently, core needle biopsy remains the gold standard f...
04
DOI 10.21037/cco-2026-1-0014
Open DOI
Research progress and trends in clinical trials for older people with colorectal cancer from 2005 to 2025: a bibliometric analysis
Background: This study aimed to conduct a bibliometric analysis of clinical trial research among older people with colorectal cancer. It presents the research landscape, highlights advancements, and reveals research hotspots, evolutionar...
05
DOI 10.21037/cco-2026-0068
Open DOI
Improving Asian American lung cancer screening awareness through virtual physician-led community outreach: quality improvement initiative
Background: Despite a significant lung cancer burden, Asian American populations have persistently low lung cancer screening (LCS) rates in the United States. This quality improvement initiative evaluated the impact of virtual, physician...
06
DOI 10.21037/cco-2026-0054
Open DOI
Revisiting neoadjuvant strategies in HER2-positive early breast cancer: are chemotherapy-sparing ADC-based approaches the next frontier?
Revisiting neoadjuvant strategies in HER2-positive early breast cancer: are chemotherapy-sparing ADC-based approaches the next frontier?
07
DOI 10.21037/cco-2026-0042
Open DOI
Locoregional therapies for intrahepatic cholangiocarcinoma: a stage-stratified, biology-informed multidisciplinary framework—a narrative review
Background and Objective: Intrahepatic cholangiocarcinoma (iCCA) is an aggressive primary liver malignancy with rising global incidence; most patients present with unresectable disease, and intrahepatic recurrence is common after curativ...
08
DOI 10.21037/cco-2026-0041
Open DOI
Vagus nerve management in lung cancer surgery: anatomical preservation, functional modulation and postoperative outcomes—a narrative review
Background and Objective: The vagus nerve plays a fundamental role in regulating bronchomotor tone, cardiac rhythm, cough reflex pathways, and neuroimmune inflammatory responses. During lung cancer surgery, particularly during mediastina...
09
DOI 10.21037/cco-2026-1-0026
Open DOI
Preliminary study on efficacy and safety of pixantrone in relapsed/refractory aggressive B-cell lymphomas: multicenter, retrospective cohort study by Polish Lymphoma Research Group (PLRG)
Background: Pixantrone (PIX) is an anthracycline derivative with reduced cardiotoxicity, registered in Poland for monotherapy in relapsed/refractory (R/R) aggressive B-cell non-Hodgkin lymphoma (B-NHL) in the third or fourth line of trea...
10
DOI 10.21037/cco-2025-aw-148
Open DOI
Drug-induced liver injury and acute pancreatitis during trastuzumab therapy in a BRCA1-mutated, HER2-positive breast cancer patient: a case report
The coexistence of a germline BRCA1 mutation and human epidermal growth factor receptor 2 (HER2)-positive breast cancer is rare and represents a distinct clinical and therapeutic challenge. The mechanisms underlying this association rema...
Bibliographical & Catalog Notes
Also issued in print.
Mode of access: World Wide Web.